Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical mechanism-based reasoning without original clinical trial data or systematic synthesis.
PubMed 10354606 · doi:10.1016/s0166-2236(98)01361-7
What was done
This paper is a narrative theoretical review synthesizing psychopharmacological, neuropathological, and neuroanatomical observations to evaluate the hypothesis of a cholinergic component of conscious awareness and selective attention.
What was found
The abstract reports no numerical findings or statistical measures. It describes qualitative observations: muscarinic antagonists reduce consciousness and induce hallucinations, nicotinic receptors are implicated in general anesthesia, Alzheimer's disease shows hypoactivity in hippocampal and cortical cholinergic projections alongside explicit memory loss, Dementia with Lewy bodies exhibits reduced neocortical acetylcholine activity linked to visual hallucinations, and Parkinson's disease involves loss of pedunculopontine cholinergic neurons associated with REM sleep disturbances.
Why it matters
It provides a conceptual framework linking ascending cholinergic pathways to consciousness, suggesting that cognitive improvements from cholinergic drugs in neurodegenerative disorders may be mediated by modulation of conscious awareness.
Limits
The review relies on narrative mechanism-based reasoning without a systematic search or quantitative data extraction. No primary human sample sizes, comparative controls, or numerical effect sizes are provided in the abstract.
Cited by
- partial Nicotine mimics the action of acetylcholine at receptors, which regulates focus and attention during the day and REM sleep at night.